Kurukulasuriya; Ravi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kurukulasuriya; Ravi.The latest application filed is for "novel compounds as indoleamine 2,3-dioxygenase inhibitors".

Company Profile

1.18.25

Kurukulasuriya; Ravi - Niantic CT
Kurukulasuriya; Ravi - Boston MA
Kurukulasuriya; Ravi - Groton CT
Kurukulasuriya; Ravi - East Lyme CT
KURUKULASURIYA; Ravi - US
Kurukulasuriya; Ravi - Gurnee IL
Kurukulasuriya; Ravi - Lake Forest IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds as indoleamine 2,3-dioxygenase inhibitors Grant 10,538,497 - Han , et al. Ja	2020-01-21
Novel Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20180362482 - Han; Yongxin ; et al.	2018-12-20
N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors Grant 9,957,265 - Dinsmore , et al. May 1, 2	2018-05-01
Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors Grant 9,957,264 - Childers , et al. May 1, 2	2018-05-01
3,3'-disubstituted indolines as inhibitors of cholesterol ester transfer protein Grant 9,688,630 - Wilson , et al. June 27, 2	2017-06-27
3,3'-disubstituted Indolines As Inhibitors Of Cholesterol Ester Transfer Protein App 20160355474 - WILSON; JONATHAN E. ; et al.	2016-12-08
Treatment of central nervous system disorders Grant 9,464,072 - Bitner , et al. October 11, 2	2016-10-11
Geminally Substituted Cyanoethylpyrazolo Pyridones As Janus Kinase Inhibitors App 20160272632 - Childers; Matthew Lloyd ; et al.	2016-09-22
Compounds that are ERK inhibitors Grant 9,233,979 - Wilson , et al. January 12, 2	2016-01-12
Compounds that are ERK inhibitors Grant 9,226,922 - Wilson , et al. January 5, 2	2016-01-05
Novel Compounds That Are Erk Inhibitors App 20150266895 - Wilson; Kevin J. ; et al.	2015-09-24
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20150265613 - Bitner; R. Scott ; et al.	2015-09-24
Novel Compounds That Are Erk Inhibitors App 20150258074 - Wilson; Kevin J. ; et al.	2015-09-17
Treatment Of Central Nervous System Disorders App 20150099740 - Bitner; R. Scott ; et al.	2015-04-09
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,993,632 - Bitner , et al. March 31, 2	2015-03-31
Treatment of central nervous system disorders Grant 8,940,902 - Bitner , et al. January 27, 2	2015-01-27
Treatment Of Central Nervous System Disorders App 20130059829 - Bitner; R. Scott ; et al.	2013-03-07
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20120289512 - Bitner; R. Scott ; et al.	2012-11-15
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,198,331 - Bitner , et al. June 12, 2	2012-06-12
Treatment Of Central Nervous System Disorders App 20100152179 - Bitner; R. Scott ; et al.	2010-06-17
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,737,137 - Brune , et al. June 15, 2	2010-06-15
Inhibitors of the 11-.beta.-hydroxysteroid dehydrogenase type 1 enzyme Grant RE41,135 - Rohde , et al. February 16, 2	2010-02-16
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090176783 - Bitner; R. Scott ; et al.	2009-07-09
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,528,282 - Rohde , et al. May 5, 2	2009-05-05
Treatment Of Central Nervous System Disorders App 20090054426 - Bitner; R. Scott ; et al.	2009-02-26
Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme App 20080312214 - Yeh; Vince S. ; et al.	2008-12-18
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,435,833 - Yeh , et al. October 14, 2	2008-10-14
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20080076819 - Yeh; Vince S. ; et al.	2008-03-27
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20070179186 - Rohde; Jeffrey J. ; et al.	2007-08-02
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,217,838 - Rohde , et al. May 15, 2	2007-05-15
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme App 20060149070 - Rohde; Jeffrey J. ; et al.	2006-07-06
Glucagon receptor antagonists/inverse agonists App 20040209928 - Kurukulasuriya, Ravi ; et al.	2004-10-21
Process for the preparation of matrix metalloproteinase inhibitors App 20020052511 - Bailey, Anne E. ; et al.	2002-05-02
Process for the selective N-formylation of N-hydroxylamines Grant 6,350,902 - Hill , et al. February 26, 2	2002-02-26
Process for the preparation of matrix metalloproteinase inhibitors App 20020019539 - Bailey, Anne E. ; et al.	2002-02-14
Process for the selective N-formylation of N-hydroxylamines App 20020002307 - Hill, David R. ; et al.	2002-01-03
Process for the selective N-formylation of N-hydroxylamines App 20010031896 - Hill, David R. ; et al.	2001-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.